 UPPSALA, Sweden, Oct. 18, 2021 PRNewswire -- Orexo AB publ., STO: ORX OTCQX: ORXOY today announced the publication of a manuscript, A Personalized, Interactive, Cognitive-Behavioral Therapy-Based Digital Therapeutic MODIATM for Adjunctive Treatment of Opioid Use Disorder: Development Study, in the Journal of Medical Internet Research JMIR Mental Health. 